Health Professionals' Opinions

This page lists 77 references in the Main Healthy Skepticism Library relevant to Health Professionals' Opinions.

Click on the HSL (Health Skepticism Library) number for more details which may include an abstract or full text.


HSL6964
Helbling J, Ajdacic-gross V, Lauber C, Weyermann R, Burns T, Rossler W.
Attitudes to antipsychotic drugs and their side effects: a comparison between general practitioners and the general population.
BMC Psychiatry 2006 Oct 18;6(1):42

HSL6105
Grace M.
Ethical marketing.
Br Dent J 2006 Apr 22;200(8):418
http://www.nature.com/doifinder/10.1038/sj.bdj.4813532

HSL4370
Hall KB, Tett SE, Nissen LM.
Perceptions of the Influence of Prescription Medicine Samples on Prescribing by Family Physicians.
Med Care 2006 Apr 1;44(4):383-387
Link to source with long URL

HSL6717
Carvalho MC, Accioly Junior H, Raffin FN.
[Social representations of generic drugs by consumers from Natal, Rio Grande do Norte, Brazil].
Cad Saude Publica 2006 Mar 01;22(3):653-61
Link to source with long URL

HSL5125
Farthing-Papineau EC, Peak AS.
Pharmacists' perceptions of the pharmaceutical industry.
Am J Health Syst Pharm 2005 Nov 15;62(22):2401-9
Link to source with long URL

HSL2671
Numerof RE, Nightingale J.
Guest Opinion: R&D Prioritization - Going beyond decision analysis
eyeforpharma Briefing 2005 Aug 17(151)
http://www.eyeforpharma.com/index.asp?nli=o&g-p&nld=8/17/2005&news=47331

HSL2266
Harvey KJ, Vitry AI., Aroni R, Ballenden N, Faggotter R.
Pharmaceutical advertisements in prescribing software: an analysis
MJA 2005 Jul 18;183(2):75-79
http://www.mja.com.au/public/issues/183_02_180705/har10263_fm.html

HSL1997
Elliott C.
Should journals publish industry-funded bioethics articles?
The Lancet 2005 Jul 6;366
Link to source with long URL

HSL2212
Hess R, Chang CC, Conigliaro J, McNeil M.
Understanding physicians' attitudes towards hormone therapy.
Womens Health Issues 2005 Jan-Feb;15(1):31-8
http://linkinghub.elsevier.com/retrieve/pii/S1049-3867(04)00103-3

HSL5282
Castresana L, Mejia R, Aznar M.
[The attitude of physicians regarding the promotion strategies of the pharmaceutical industry].
Medicina (B Aires) 2005;65(3):247-51

HSL1897
Douglas KM, Sutton RM.
Right about others, wrong about ourselves? Actual and perceived self-other differences in resistance to persuasion
Br J Soc Psychol 2004 Dec;43(Pt 4):585-603
Link to source with long URL

HSL2215
Aasland OG, Forde R.
[Physicians and drug industry: attitudes and practice].
Tidsskr Nor Laegeforen 2004 10 21;124(20):2603-6
http://www.tidsskriftet.no/pls/lts/pa_lt.visSeksjon?vp_SEKS_ID=1083681

HSL1360
Toivianen H, Vuorenkoski L, Hemminki E.
Finnish physicians show little support for consumer advertising of prescription drugs.
N Z Med J 2004 Jun 4;117(1195):U907

HSL1351
Watkins RS, Kimberly J Jr.
What residents don't know about physician-pharmaceutical industry interactions.
Acad Med 2004 May;79(5):432-7
http://www.academicmedicine.org/cgi/content/full/79/5/432

HSL2152
Keim SM, Mays MZ, Grant D.
Interactions between emergency medicine programs and the pharmaceutical industry.
Acad Emerg Med 2004 Jan;11(1):19-26
http://www.aemj.org/cgi/content/full/11/1/19

HSL2227
Rutledge P, Crookes D, McKinstry B, Maxwell SR.
Do doctors rely on pharmaceutical industry funding to attend conferences and do they perceive that this creates a bias in their drug selection? Results from a questionnaire survey.
Pharmacoepidemiol Drug Saf. 2003 Dec 01;12(8):663-7.
Link to source with long URL

HSL2239
Monaghan MS, Galt KA, Turner PD, Houghton BL, Rich EC, Markert RJ, Bergman-Evans B.
Student understanding of the relationship between the health professions and the pharmaceutical industry.
Teach Learn Med 2003 Win;15(1):14-20

HSL4276
Brett AS, Burr W, Moloo J.
Are gifts from pharmaceutical companies ethically problematic? A survey of physicians
Archives of Internal Medicine 2003 Oct 13;163(18):2213-2218
Link to source with long URL

HSL6023
Mansfield PR.
Drug marketing deserves recognition
BMJ 2003 Aug 28;327
http://bmj.bmjjournals.com/cgi/eletters/327/7413/468-d

HSL2519
Liberati A, Magrini N.
Information from drug companies and opinion leaders.
BMJ 2003 May 31;326(7400):1156-7
http://bmj.bmjjournals.com/cgi/content/full/326/7400/1156

HSL2144
Chakrabarti A, Fleisher WP, Staley D, Calhoun L.
Interactions of staff and residents with pharmaceutical industry: a survey of psychiatric training program policies.
Ann R Coll Physicians Surg Can 2002 Dec;35(8)

HSL2296
Quinn RJ, O'Neill C.
Attitudes of general practitioners to their interactions with pharmaceutical companies: a qualitative study.
Ir Med J 2002 Jul-Aug;95(7):199-202
Link to source with long URL

HSL2444
Young JM, Glasziou P, Ward JE.
General practitioners' self ratings of skills in evidence based medicine: validation study.
BMJ 2002 Apr 20;324(7343):950-1
http://bmj.bmjjournals.com/cgi/content/full/324/7343/950

HSL2168
Steinman MA, Shlipak MG, McPhee SJ.
Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions.
Am J Med 2001 May;110(7):551-7
http://linkinghub.elsevier.com/retrieve/pii/S000293430100660X

HSL2975
Croft A, Geary K, Morgan L.
Efficacy of atovaquone-proguanil? (1st of 2 letters)
The Lancet 2001 Apr 21;357:1289

HSL349
Guldal D, Semin S.
The influences of drug companies' advertising programs on physicians
Int J Health Serv 2000;30(3):585-95
Nil

HSL549
Day R.
Pharmaceutical company promotion: striking a balance.
Aust N Z J Med 1998 Jun;28(3):291-3
Nil

HSL547
Gibbons RV, Landry FJ, Blouch DL, Jones DL, Williams FK, Lucey CR, Kroenke K.
A comparison of physicians' and patients' attitudes toward pharmaceutical industry gifts.
J Gen Intern Med 1998 Mar;13(3):151-4
http://www.blackwell-synergy.com/doi/abs/10.1046/j.1525-1497.1998.00048.x

HSL2443
McColl A, Smith H, White P, Field J.
General practitioner's perceptions of the route to evidence based medicine: a questionnaire survey.
BMJ 1998 Jan 31;316(7128):361-5
http://bmj.bmjjournals.com/cgi/content/full/316/7128/361

HSL704
Lipsky MS, Taylor CA.
The opinions and experiences of family physicians regarding direct-to-consumer advertising.
J Fam Pract 1997 Dec;45(6):495-9

HSL701
Madhavan S, Amonkar MM, Elliott D, Burke K, Gore P.
The gift relationship between pharmaceutical companies and physicians: an exploratory survey of physicians.
J Clin Pharm Ther 1997 Jun;22(3):207-15
Nil

HSL703
MacKowiak ED, O'Connor TW, Geller H, Nguyen J, Wilkes W.
A survey of pharmacists' and pharmacy students' attitudes toward OTC advertising
Journal of Pharmaceutical Marketing & Management 1997;12(1):33-49

HSL756
Strang D, Gagnon M, Molloy W, Bedard M, Darzins P, Etchells E, Davidson W.
National survey on the attitudes of Canadian physicians towards drug-detailing by pharmaceutical representatives.
Ann R Coll Physicians Surg Can 1996 Dec;29(8):474-8

HSL2186
Kelly MH, Murray TS.
Motivation of general practitioners attending postgraduate education.
Br J Gen Pract 1996 Jun;46(407):353-6

HSL807
Amonkar MM, Lively BT.
Pharmacists' attitudes toward product-specific television advertising of prescription drugs
J Pharm Mark Manage 1996;11(2):3-20

HSL809
Aldir RE, Jarjoura D, Phinney M, Poordad F, Gutierrez R, Marnejon T, Greifenstein E, Lappin J, Whittier FC.
Practicing and resident physician’s views on pharmaceutical companies.
J Contin Educ Health Prof 1996;16:25-32

HSL833
Mabin DC.
BMJ should declare its own conflict of interest.
BMJ 1995 Sep 30;311(7009):878-9
http://www.bmj.com/cgi/content/full/311/7009/878/b

HSL829
Petroshius SM, Titus PA, Hatch KJ.
Physician attitudes toward pharmaceutical advertising
J Advert Res 1995;35(6):41-51

HSL1721
Andaleeb SS, Tallman RF.
Physician attitudes toward pharmaceutical sales representatives.
Health Care Manage Rev 1995 Sum;20(3):68-76

HSL6722
Leisinger KM.
Professional organizations and healthcare industry support: ethical conflict. Commentary
Cambridge Quarterly of Healthcare Ethics 1994;3:244-247

HSL5785
Reeder M, Dougherty J, White LJ.
Pharmaceutical representatives and emergency medicine residents: a national survey.
Ann Emerg Med 1993 Oct;22(10):1593-6
Link to source with long URL

HSL5137
Shapiro MF.
Critics dissect, authors defend Wilkes paper on advertising [author's response]
Medical Marketing & Media 1992 Dec 1;27(12):18-19

HSL5134
Jacoby , J .
Critics dissect, authors defend Wilkes paper on advertising [1st of 4 critiques]
Medical Marketing & Media 1992 Nov 5;27(12):16-17

HSL5135
Rubin , Paul H.
Critics dissect, authors defend Wilkes paper on advertising [3rd of 4 critiques]
Medical Marketing & Media 1992 Nov 1;27(12):17-18

HSL5136
Schmittlein , David .
Critics dissect, authors defend Wilkes paper on advertising [2nd of 4 critiques]
Medical Marketing & Media 1992 Nov 1;27(12):17

HSL5139
Wilkes MS.
Critics dissect, authors defend Wilkes paper on advertising [summary of the research]
Medical Marketing & Media 1992 Nov 1;27(12):15-16

HSL2180
Banks JW 3rd, Mainous AG 3rd.
Attitudes of medical school faculty toward gifts from the pharmaceutical industry.
Acad Med 1992 Sep;67(9):610-2

HSL2182
Lichstein PR, Turner RC, O'Brien K.
Impact of pharmaceutical company representatives on internal medicine residency programs. A survey of residency program directors
Arch Intern Med. 1992 May;152(5):1009-13.

HSL4884
O’regan JB.
Physicians and pharmaceutical companies
Canadian Medical Association Journal 1992;146:329, 332

HSL4919
Tarshis GA.
Pharmaceutical promotion
New England Journal of Medicine 1992;327:1686

HSL5968
Lomas J, Enkin M, Anderson GM, Hannah WJ, Vayda E, Singer J.
Opinion leaders vs audit and feedback to implement practice guidelines Delivery after previous cesarean section.
JAMA 1991 May 1;265(17):2202-7

HSL4652
Cutrer CM, Pleil AM.
Potential outcomes associated with direct-to-consumer advertising of prescription drugs: physicians’ perspectives
Journal of Pharmaceutical Marketing & Management 1991;5(3-19)

HSL2193
McKinney WP, Schiedermayer DL, Lurie N, Simpson DE, Goodman JL, Rich EC.
Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives.
JAMA 1990 Oct 3;264(13):1693-7

HSL2194
Lurie N, Rich EC, Simpson DE, Meyer J, Schiedermayer DL, Goodman JL, McKinney WP.
Pharmaceutical representatives in academic medical centers: interaction with faculty and housestaff.
J Gen Intern Med 1990 May-Jun;5(3):240-3

HSL4523
Cockerill R.
Report on the 1989 survey of the dispensing practices and attitudes toward prescription drugs of Ontario pharmacists
1990

HSL4593
Information or communication? A consumer study of television advertising
Taylor Nelson Research 1990

HSL4604
Williams AP, Cockerill R.
Report on the 1989 survey of the prescribing experiences and attitudes toward prescription drugs of Ontario physicians
1990

HSL4126
Bell KD.
Regulating drug advertisements
Lancet 1989;2:678

HSL4128
Bressler R.
Endorsement of “patient promise” program
Lancet 1989;320:1355

HSL4003
Heilman SR.
“A matter of influence”: graduate medical education and commercial sponsorship
New England Journal of Medicine 1988;318:53

HSL4014
Lefkowitz D.
Rap sheet on reps: the doctor will see you now
Pharmaceutical Executive 1988;8(6)

HSL4024
Mossinghoff GJ.
Costs of drug advertising
New England Journal of Medicine 1988;319:798

HSL3765
Blum AL, Chalmers TC, Deutsch E, Koch-weser J, Langman M, Rosen A, Tygstrup N, Zentgraf R.
Differing attitudes of industry and academia towards controlled clinical trials
European Journal of Clinical Investigation 1986;16:455-460

HSL3768
Burley DM.
Should a drug company employee edit a medical journal?
Lancet 1986;1(801)

HSL3743
Mansfield PR.
Protecting the innocent from harm: the Medical Lobby for Appropriate Marketing (MLAM)
New Doctor 1985 Jun(36):22-24

HSL3690
Joubert PH, Skene D.
Attitudes of private medical practitioners towards package inserts and other drug information sources.
S Afr Med J 1984 Aug 25;66(8):306-7

HSL3616
MLAM
Lancet 1984;2:861

HSL3660
Walden RJ.
Doctors and the drug makers
Lancet 1984;2:405

HSL3662
Wright T.
Legibility of advertisements
Lancet 1984;2:1396

HSL3457
Tannock IF.
Responsibility in advertising: an oncologist's view
New England Journal of Medicine 1979 Nov 1;300:1004

HSL3301
Eaton G, Parish P.
General practitioners' views of information about drugs.
J R Coll Gen Pract 1976;26

HSL3343
Stetler CJ.
Advertising of prescription medicines.
Journal of Drug Issues 1976;6(1):34-42

HSL3344
Watson M.
A physician views drug advertising
Journal of Drug Issues 1976;6(1)

HSL3278
Prather J, Fidell LS.
Sex differences in the content and style of medical advertisements.
Soc Sci Med 1975 Jan;9(1):23-6

HSL3279
Smith GH, Sorby DL, Sharp LJ.
Physician attitudes toward drug information resources.
Am J Hosp Pharm 1975 Jan;32(1):19-25

HSL3267
Siegelman S.
How pharmacists rate detailmen
American Druggist 1974 Aug 1;170(3):19, 56-62

HSL2687
Becker MH, Stolley PD, Lasagna L, McEvilla JD, Sloane LM.
Characteristics and attitudes of physicians associated with the prescribing of chloramphenicol.
HSMHA Health Rep 1971 Nov;86(11):993-1003
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&DB=pubmed